Literature DB >> 12011297

High age-adjusted prevalence of Parkinson's disease among Inuits in Greenland.

Lene Wermuth1, Henning Pakkenberg, Bernard Jeune.   

Abstract

The prevalence of PD among Inuits in Greenland has not been determined. The authors found 40 patients with PD at the prevalence date January 1, 2000. The crude prevalence of PD was estimated to be 81.0 per 100.000 inhabitants born in Greenland. However, owing to the low proportion of 50+ year old Inuits (16.5 vs 33.5% in Denmark) the age-adjusted prevalence was much higher-187.5 per 100,000 persons.

Entities:  

Mesh：

Year:  2002        PMID： 12011297     DOI： 10.1212/wnl.58.9.1422

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  8 in total

1.  Elevated serum pesticide levels and risk of Parkinson disease.

Authors:  Jason R Richardson; Stuart L Shalat; Brian Buckley; Bozena Winnik; Padraig O'Suilleabhain; Ramon Diaz-Arrastia; Joan Reisch; Dwight C German
Journal:  Arch Neurol       Date:  2009-07

Review 2.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

3.  Prevalence of Parkinson disease among the Navajo: a preliminary examination.

Authors:  Paul H Gordon; Hongwei Zhao; Denise Bartley; Lt James G Sims; Mae-Gilene Begay; Sarah Pirio Richardson; Johnnye Lewis; Andrew S Rowland
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

4.  Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.

Authors:  Jesús de Pedro-Cuesta; Pablo Martínez-Martín; Alberto Rábano; Enrique Alcalde-Cabero; Fernando José García López; Javier Almazán-Isla; María Ruiz-Tovar; Maria-José Medrano; Fuencisla Avellanal; Olga Calero; Miguel Calero
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

5.  Organochlorine pesticide levels in Greek patients with Parkinson's disease.

Authors:  Efthimios Dardiotis; Athina-Maria Aloizou; Evagelos Sakalakis; Vasileios Siokas; Michalis Koureas; Georgia Xiromerisiou; Efthymia Petinaki; Martin Wilks; Aristidis Tsatsakis; Christos Hadjichristodoulou; Leonidas Stefanis; Georgios M Hadjigeorgiou
Journal:  Toxicol Rep       Date:  2020-04-08

6.  Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severity.

Authors:  Nabila Dahodwala; Amy R Pettit; Jordan Jahnke; Pengxiang Li; Vrushabh P Ladage; Prasanna L Kandukuri; Jorge Zamudio; Yash J Jalundhwala; Jalpa A Doshi
Journal:  Clin Park Relat Disord       Date:  2020-02-26

7.  Disease-Related Variables and Depression Among Iranian Patients with Parkinson Disease.

Authors:  Jalal Shakeri; Maryam Chaghazardi; Nasrin Abdoli; Farid Arman; Seyed Davood Hoseini; Hania Shakeri
Journal:  Iran Red Crescent Med J       Date:  2015-10-28       Impact factor: 0.611

8.  Etiologic Framework for the Study of Neurodegenerative Disorders as Well as Vascular and Metabolic Comorbidities on the Grounds of Shared Epidemiologic and Biologic Features.

Authors:  Jesús de Pedro-Cuesta; Pablo Martínez-Martín; Alberto Rábano; María Ruiz-Tovar; Enrique Alcalde-Cabero; Miguel Calero
Journal:  Front Aging Neurosci       Date:  2016-06-13       Impact factor: 5.750
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.